HMGB1: A Therapeutic Target for Myocardial Infarction-Juniper Publishers
JUNIPER PUBLISHERS - OPEN ACCESS JOURNAL OF CARDIOLOGY & CARDIOVASCULAR THERAPY Abstract Myocardial ischemia/reperfusion injury is a major socioeconomic problem worldwide. Though there are wider advancements, still mortality rate is substantial. This can be overcome by exploring complete pathopysiology of the disease mechanism. High-mobility group box-1 (HMGB1) is recently explored multifunctional protein based on its location. The present short communication gives an idea on multiple biological activities of HMGB1. Introduction Myocardial infarction (MI) is the leading cause of death worldwide. Atherosclerotic plaque formation, blocks the coronary artery and there by leads to MI. Early reperfusion is required to salvage diseased myocardium. Reperfusion in turn damages the myocardium called as reperfusion injury ( Figure 1 ). Myocardial ischemia/reperfusion (I/R) injury aggravates the area of infarction. Though t...